Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Shaw

Showing results (991-1000 of 1,001) with videos related to

Pageof 101
Sort By:
Cell|February 12, 2019
Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac DiseaseToufic Mayassi, Kristin Ladell, Herman Gudjonson, et al.
Nature Medicine|June 15, 2023
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitisDustin G Shaw, Raúl Aguirre-Gamboa, Marcos C Vieira, et al.
Radiation Research|December 4, 2003
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003C Norman Coleman, Helen B Stone, George A Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
The Journal of Experimental Medicine|October 9, 2025
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2Siriruk Changrob, Atsuhiro Yasuhara, Suncheol Park, et al.
Immunity|May 22, 2021
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targetsHaley L Dugan, Christopher T Stamper, Lei Li, et al.
Journal of Internal Medicine|October 9, 2020
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trialM L L Madariaga, J J Guthmiller, S Schrantz, et al.
BMC Systems Biology|November 7, 2015
A multi-omic analysis of human naïve CD4+ T cellsChristopher J Mitchell, Derese Getnet, Min-Sik Kim, et al.
Immunity|March 25, 2025
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutininsJenna J Guthmiller, Linda Yu-Ling Lan, Lei Li, et al.
The Lancet. Infectious Diseases|October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trialDavid I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Pageof 101

Showing results (991-1000 of 1,001) with videos related to

Sort By:
Pageof 101
Cell|February 12, 2019
Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac DiseaseToufic Mayassi, Kristin Ladell, Herman Gudjonson, et al.
Nature Medicine|June 15, 2023
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitisDustin G Shaw, Raúl Aguirre-Gamboa, Marcos C Vieira, et al.
Radiation Research|December 4, 2003
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003C Norman Coleman, Helen B Stone, George A Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
The Journal of Experimental Medicine|October 9, 2025
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2Siriruk Changrob, Atsuhiro Yasuhara, Suncheol Park, et al.
Immunity|May 22, 2021
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targetsHaley L Dugan, Christopher T Stamper, Lei Li, et al.
Journal of Internal Medicine|October 9, 2020
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trialM L L Madariaga, J J Guthmiller, S Schrantz, et al.
BMC Systems Biology|November 7, 2015
A multi-omic analysis of human naïve CD4+ T cellsChristopher J Mitchell, Derese Getnet, Min-Sik Kim, et al.
Immunity|March 25, 2025
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutininsJenna J Guthmiller, Linda Yu-Ling Lan, Lei Li, et al.
The Lancet. Infectious Diseases|October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trialDavid I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Pageof 101